Processa Pharmaceuticals, Inc. Interest Payable
Processa Pharmaceuticals, Inc. (PCSA) had Interest Payable of $84.51 thousand as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2021-03-25
- 2020-12-31: Interest Payable $84.51K.
- 2019-12-31: Interest Payable $28.93K.
- 2018-12-31: Interest Payable $114.33K; Interest Payable as first filed $109.47K.
- 2017-09-29: Interest Payable $613.11K.
| Period end | Interest Payable | Interest Payable as first filed |
|---|---|---|
| 2020-12-31 | $84.51K 10-K · filed 2021-03-25 | |
| 2019-12-31 | $28.93K 10-K · filed 2021-03-25 | |
| 2018-12-31 | $114.33K 10-K · filed 2020-03-06 | $109.47K 10-K · filed 2019-03-28 |
| 2017-09-29 | $613.11K 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |